Circulating MMP-12 as Potential Biomarker in Evaluating Disease Severity and Efficacy of Sublingual Immunotherapy in Allergic Rhinitis

Table 4

Demographics and clinical characteristics of effective and ineffective group 3 years post-SLIT.

Variables		Effective group ()	Ineffective group ()	value
Sex				0.515
Male		25 (41.7%)	10 (50.0%)
Female		35 (58.3%)	10 (50.0%)
Age, years				0.067
BMI, kg/m^2				0.223
Smoking, yes/no		29/31	10/10	0.897
Drinking, yes/no		29/31	12/8	0.366
Baseline VAS				0.034
Baseline TNSS			0.766

BMI: body mass index; VAS: visual analogue scales; TNSS: total nasal symptoms score; SLIT: sublingual immunotherapy.